Photodynamic therapy to treat choroidal neovascularisation in highly myopic patients: 4 Years' outcome

British Journal of Ophthalmology

Volumn 92, Issue 6, 2008, Pages 792-794

  Ruiz Moreno, J M ^a,b,c   Amat, P ^b   Montero, J A ^b   Lugo, F ^b  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Alicante   (Spain)

^c Catedrático de Oftalmología ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VERTEPORFIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE STUDY; CHORIORETINAL ATROPHY; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERVENTION STUDY; MALE; MULTIPLE REGRESSION; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DISEASE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGE FACTORS; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOPIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; REFRACTIVE ERRORS; REGRESSION ANALYSIS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 45249102006     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.132795     Document Type: Article

References (22)

1. Curtin B. The myopias: basic science and clinical management. Philadelphia: Harper & Row, 1985:7-10.
2. Hotchkiss ML, Fine SL. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 1981;91:177-83.
3. Ohno-Matsui K, Moriyama M, Hayashi K, et al. Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2006;244:1363-6.
4. Ruiz-Moreno JM, Montero JA. Long-term visual acuity after argon green laser photocoagulation of juxtafoveal choroidal neovascularization in highly myopic eyes. Eur J Ophthalmol 2002;12:117-22.
5. Kobayashi H, Kobayashi K. Radiotherapy for subfoveal neovascularisation associated with pathological myopia: a pilot study. Br J Ophthalmol 2000;84:761-6.
6. Ruiz-Moreno JM, de la Vega C. Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol 2001;85:1041-3.
7. Fujikado T, Ohji M, Saito Y, et al. Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy. Am J Ophthalmol 1998;125:647-56.
8. Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-6.
9. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye 2001;15:407-12.
10. Ruiz-Moreno JM, Montero JA. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes. Br J Ophthalmol 2003;87:856-9.
11. Krebs I, Binder S, Stolba U, et al. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy. Am J Ophthalmol 2005;140:416-25.
12. Chan WM, Lai TY, Wong AL, et al. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol 2007;91:174-9.
13. Verteporfin In Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-52.
14. Avila MP, Weiter JJ, Jalkh AE, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-81.
15. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003;110:1297-305.
16. Pace A, Vadala M, Isola V, et al. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study. Am J Ophthalmol 2007;143:449-54.
17. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 2002;109:712-9.
18. Curcio CA, Saunders PL, Younger PW, et al. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photoreceptor loss. Ophthalmology 2000;107:334-43.
19. Varano M, Parisi V, Tedeschi M, et al. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation. Invest Ophthalmol Vis Sci 2005;46:1453-62.
20. Marticorena J, Gomez-Ulla F, Fernandez M, et al. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. Am J Ophthalmol 2006;142:335-7.
21. Yamamoto I, Rogers AH, Reichel E, et al. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 2007;91:157-60.
22. Virgili G, Varano M, Giacomelli G, et al. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia. Am J Ophthalmol 2007;143:77-82.